Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,027 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC.
Bando H, Kotani D, Satake H, Hamaguchi T, Shiozawa M, Kotaka M, Masuishi T, Yasui H, Kagawa Y, Komatsu Y, Oki E, Yamamoto Y, Kawakami H, Misumi T, Taniguchi H, Yamazaki K, Muro K, Yoshino T, Kato T, Tsuji A. Bando H, et al. Among authors: yamamoto y. Med. 2024 Jun 14:S2666-6340(24)00216-2. doi: 10.1016/j.medj.2024.05.012. Online ahead of print. Med. 2024. PMID: 38901425
Predictive validity of Lupus Patient-Reported Outcome for damage accrual in patients with systemic lupus erythematosus: the LUNA Registry.
Nose Y, Onishi A, Nishimura K, Yamamoto Y, Sada KE, Ichinose K, Yoshimi R, Ohno S, Yanai R, Kajiyama H, Sato S, Shimojima Y, Fujiwara M, Kida T, Miyawaki Y, Matsuo Y, Tsuji H, Morinobu A, Saegusa J. Nose Y, et al. Among authors: yamamoto y. Rheumatology (Oxford). 2024 Jun 17:keae341. doi: 10.1093/rheumatology/keae341. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38885408
12,027 results
You have reached the last available page of results. Please see the User Guide for more information.